XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Cost of Goods Sold
9 Months Ended
Sep. 30, 2012
Cost of Goods Sold [Abstract]  
Cost of Goods Sold
Note 4:
Cost of Goods Sold

The majority of the Company's inventory was purchased prior to obtaining authorization to affix the CE Mark to its Generation Two Delcath Hepatic CHEMOSAT® Delivery System in April 2012, including all of the components used in the kits sold during the nine months ended September 30, 2012. Additionally, the kits were built during the quarter ended March 31, 2012 and accordingly, all labor and overhead related to the kits was expensed during the first quarter. As a result, the costs of sales related to recognized and deferred revenue was $0.